Bernd Hentsch
Director/Board Member at G2M Cancer Drugs AG
Bernd Hentsch active positions
| Companies | Position | Start | End |
|---|---|---|---|
G2M Cancer Drugs AG
 G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Director/Board Member | 31/12/2000 | - |
Career history of Bernd Hentsch
Former positions of Bernd Hentsch
| Companies | Position | Start | End |
|---|---|---|---|
| 4SC AG | Corporate Officer/Principal | 10/05/2010 | - |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Bernd Hentsch
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Statistics
International
| Germany | 4 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoral
| Retail Trade | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| 4SC AG | Health Technology |
| Private companies | 2 |
|---|---|
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
G2M Cancer Drugs AG
G2M Cancer Drugs AG Miscellaneous Commercial ServicesCommercial Services Part of Valerio Therapeutics SA, G2M Cancer Drugs AG is a German company that researches new anti-cancer therapeutics and develops selected late-stage products. The company is based in Frankfurt am Main, Germany. G2M Cancer Drugs was acquired by Topotarget A/S on March 01, 2005. | Commercial Services |
- Stock Market
- Insiders
- Bernd Hentsch
- Experience
